GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's quarterly other assets (bank) increased from Dec. 2013 ($417.34 Mil) to Mar. 2014 ($586.37 Mil) but then declined from Mar. 2014 ($586.37 Mil) to Jun. 2014 ($549.53 Mil).
Synageva BioPharma Corp's annual other assets (bank) increased from Dec. 2011 ($62.50 Mil) to Dec. 2012 ($222.55 Mil) and increased from Dec. 2012 ($222.55 Mil) to Dec. 2013 ($417.34 Mil).
Banks frequently group a variety of accounts as other assets on their balance sheets. Banks must report several of these accounts, such as investment in unconsolidated subsidiaries, customer liability on outstanding acceptances, and intangible assets as separate line items on Call Reports.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data